Life Science Tools Market To Reach USD 400.2 Billion By 2032 | DataHorizzon Research

The life science tools market size was valued at USD 162.4 Billion in 2023 and is expected to reach a market size of USD 400.2 Billion by 2032 at a CAGR of 10.5%.

Fort Collins, Colorado, April 25, 2024 (GLOBE NEWSWIRE) —

The rise in demand for personalized medicine represents growth opportunities for the life science tools market.

The growing demand for personalized medicine signifies a substantial opportunity for the life science tools market. Personalized medicine endeavors to customize medical treatments based on an individual’s genetic makeup, lifestyle factors, and environmental influences, yielding more precise and efficacious therapies. The advancement of personalized medicine critically hinges on using advanced life science tools, including genomic sequencing, molecular diagnostics, and bioinformatics platforms. According to a report by the Personalized Medicine Coalition, the proportion of personalized medicines receiving approval from the U.S. Food and Drug Administration (FDA) has surged from 5% of all new drug approvals in 2005 to 25% in 2020. This trajectory is poised to persist, fueled by the deepening comprehension of disease biology and the growing collaboration among pharmaceutical firms, diagnostic developers, and providers of life science tools.

Rapid progress in genomics and proteomics technologies has revolutionized the life sciences industry, propelling the growth of the Life Science Tools market. With the declining costs of DNA sequencing and the increasing accessibility of high-throughput technologies, researchers can now generate vast quantities of genomic and proteomic data. According to the National Human Genome Research Institute (NHGRI), the expense of sequencing a human genome has plummeted from around $10 million in 2007 to less than USD 1,000 in 2021. This dramatic cost reduction has spurred the widespread adoption of genomic and proteomic methodologies in various domains, such as drug discovery, precision medicine, and disease diagnosis. Consequently, there is a robust demand for life science tools capable of efficiently processing and analyzing this abundance of data. 

Request Sample Report:

Segmentation Overview:

The life science tools market has been segmented into product, technology, application, end-user, and region.

Consumables are the fast-growing tools segment in the forecast period.

  • Based on the market segmentation for life science tools by product, consumables are the largest segment for 2023. Consumables, including reagents, kits, and other disposable items, are essential in various life science research and diagnostic applications. 

Genomics is the leading segment in the forecast period.

  • Based on the market segmentation for life science tools by technology, genomics was the largest segment in 2023. Genomics technology has revolutionized life science research by enabling scientists to study the complete set of an organism’s genetic material, leading to significant advancements in understanding disease mechanisms, identifying drug targets, and developing personalized therapies. 

Ask For Discount

Life Science Tools Market Report Highlights:

  • The life science tools market growth is anticipated at a CAGR of 10.5% by 2032.
  • Rise in research and development expenses to drive the demand for life science tools.
  • The Asia-Pacific region is a fast-growing market for life science tools, owing to the rapid expansion of the pharmaceutical and biotech industries.
  • Some prominent players in the life science tools market report include Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Merck KGaA, Illumina, Bio-Rad Laboratories, Becton, Dickinson and Company, PerkinElmer, Qiagen, Waters Corporation, Shimadzu Corporation, and Bruker Corporation. 

Looking Exclusively For Region/Country Specific Report?

About DataHorizzon Research:

DataHorizzon is a market research and advisory company that assists organizations across the globe in formulating growth strategies for changing business dynamics. Its offerings include consulting services across enterprises and business insights to make actionable decisions. DHR’s comprehensive research methodology for predicting long-term and sustainable trends in the market facilitates complex decisions for organizations.



Ph: +1-970-672-0390


Follow Us: LinkedIn 


Recent Publications

Pain Management Devices Market 2024 to 2032

Injectable Drug Delivery Market 2024 to 2032

Drug Discovery Services Market 2024 to 2032

Fetal Bovine Serum Market 2024 to 2032

Behavioral Health Market 2024 to 2032

CONTACT: Mail: Ph: +1-970-672-0390 Website: 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy